(Q38491112)

English

Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.

scientific article published on December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

A B Jani

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

F Vaida

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

G Hanks

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S Asbell

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

O Sartor

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

J W Moul

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M Roach

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

D Brachman

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

U Kalokhe

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

R Muller-Runkel

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

P Ray

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

L Ignacio

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Awan

13

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

R R Weichselbaum

14

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S Vijayakumar

15

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

363-371

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Prostate carcinoma incidence and patient mortality: the effects of screening and early detection.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

The diagnosis and reporting of adenocarcinoma of the prostate in core needle biopsy specimens

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

The role of increasing detection in the rising incidence of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Changing trends in U.S. prostate cancer incidence rates

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Prostate cancer incidence and mortality rates among white and black men.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Prostate cancer histologic trends in the metropolitan Detroit area, 1982 to 1996.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Long-term survival among men with conservatively treated localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Changes in prostate cancer incidence and treatment in USA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1035

21 January 2018

Identifiers

10.1002/IJC.1035

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38491112&oldid=2123115823"